A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
Clinical trial NCT06049329 · COMPLETED
Trial details
- NCT number
- NCT06049329
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2023-12-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.